James Love's blog
This was the KEI intervention at SCCR 30 on the topic of preservation exceptions for libraries and archives.
Preservation is obviously important for everyone, and archiving in general is both a local benefit and to some degree, a global public good.
We want works preserved, and copyright and trade negotiators to sort out the issues regarding access, which will often be context specific.
Every country's copyright laws should have as a minimum an exception for preservation.
This is the document being discussed Thursday at #sccr30
Thanks to John E. Miller for the OCR version.
This is the prepared statement that Iran read on Wed, which was widely praised by access to known advocates.
Iran’s Statement on the limitations and exceptions
1 July 2015
The right to science, knowledge and culture is recognized in various basic human rights instruments, such as the International Covenant on Economic, Social and Cultural Rights.
This is from the statement India read today at SCCR 30, on the topic of the broadcast treaty.
India is flexible in supporting the issue of unauthorized live transmission of signal over computer networks provided the broadcasting organization has rights over the content broadcast by it. India alternative proposals submitted at 26th session of SCCR are in complete conformity with the mandate of the 2007 WIPO General Assembly.
Today we are in endless "informational" session, chaired by John Simpson from the BBC, and featuring big broadcasters from India (Zee Network), and Brazil (TV Globo), ABN Holdings Ltd (ABN) (A company headquartered England, about) and the Caribbean Communications Network Limited.
Among House Democrats supporting Fast Track, 24 of 28 received money from drug and medical device PACSSubmitted by James Love on 21. June 2015 - 8:17
I spent a bit of time to look at the contributions from selected drug and medical device Political Action Committees (PACs) to the 28 House Democrats who voted for fast track on June 18, 2015.
We just received a reply from a September 17, 2013 FOIA request KEI filed with USTR, asking for correspondence involving General Electric's efforts to block the WIPO Treaty for the Blind. USTR provided 24 pages of documents, available here:
Following the Friday vote in the House of Representatives which effectively blocked movement (for now) on the Trade Promotion Authority, and more generally, slowed down the TransPacific Partnership (TPP) negotiations, I was contacted by Dr. Harvey Bale, the well known former Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). In an exchange on Facebook, Dr. Bale took favorable note of the outcome on fast track, and described the vote against fast track as "A very good day, Indeed." I asked Dr.
I have written an article for Medium, titled: TPP, designed to make medicine more expensive, reforms more difficult. (Link here)
Last week, KEI published the October 3, 2014 Korea proposals for the RCEP IP Chapter (http://www.keionline.org/node/2239), and earlier we published a Japan proposal for the RCEP IP Chapter (http://keionline.org/node/2173)
Today we are publishing two new proposals for the RCEP IP Chapter, the proposals by
- India, and
US Copyright office proposes limits on damages, injunctions, for Orphan Works, contradicting TPP languageSubmitted by James Love on 4. June 2015 - 15:51
The US Copyright Office has proposed limitations on damages and injunctions, when "orphan" copyrighted works are infringed.
Attached (here) is the October 3, 2014 version of the Draft Text, of the Intellectual Property Chapter, for the Regional Comprehensive Economic Partnership (RCEP), Free Trade Agreement, tabled by South Korea in the negotiations. (More about the RCEP here)
The next round of negotiation will be held in Kyoto, Japan from 8-12 June.
The TPP, following a plethora of other trade agreements involving the United States, the European Union and Japan as trading partners, seeks to expand and extend drug monopolies, by requiring lower standards for the grant of patents, extensions of patent terms, exclusive rights in test data, among other measures. These proposals and polices are designed to have the predictable effect of making drug prices higher.
KEI comments to DHHS on WHA agenda 17.4, the Consultative Expert Working Group on Research and DevelopmentSubmitted by James Love on 8. May 2015 - 9:47
Re: 17.4 Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination Document A68/34
My name is James Love, from Knowledge Ecology International. I wanted to discuss the negotiations on new approaches to funding medical R&D.
I will begin with the much delayed discussions about a WHO R&D treaty, which are supposed to resume in 2016.
We have suggestions for some changes in the discussion, to move things forward.